PPARγ also forms heterodimers with RXRα, and anti-inflammatory effects and amelioration of experimental colitis has been described with a number of PPARγ agonists through trans-repression of signal-dependent transcription factors that mediate inflammatory programs of gene activation (Linard et al., 2008). The gene discussed is RXRA; the disease is colitis.